SC Pharmaceuticals Inc (SCPH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.13 +0.13 (+4.33%) 03/24/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.10 -0.03 (-0.96%) 17:51 ET
for Mon, Mar 24th, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 72,624 | 89,478 | 118,298 | 39,282 | 1,573 |
Receivables | 310 | 479 | 655 | 349 | 104 |
Other current assets | 94 | 179 | 107 | 8 | 15 |
TOTAL | $75,647 | $91,893 | $119,883 | $39,740 | $1,818 |
Non-Current Assets | |||||
PPE Net | 127 | 164 | 203 | 26 | 23 |
Other Non-Current Assets | 1,509 | 1,698 | 1,962 | 6 | 5 |
TOTAL | $1,636 | $1,862 | $2,165 | $32 | $28 |
Total Assets | $77,283 | $93,755 | $122,048 | $39,772 | $1,846 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | 2,811 | 314 | N/A | N/A |
Accounts payable and accrued liabilities | 1,142 | 587 | 1,591 | 1,546 | 684 |
Accrued Expenses | 3,688 | 2,922 | 3,063 | 2,178 | 1,293 |
Other current liabilities | N/A | N/A | 1 | 12 | 28 |
TOTAL | $5,237 | $6,673 | $5,211 | $3,736 | $2,005 |
Non-Current Liabilities | |||||
Long Term Debt | 18,915 | 6,826 | 9,105 | N/A | N/A |
aiOther Non-Current Liabilities | 1,766 | 1,512 | 1,735 | 7 | 8 |
TOTAL | $20,681 | $8,338 | $10,840 | $7 | $8 |
Total Liabilities | $25,918 | $15,011 | $16,051 | $3,743 | $2,013 |
Shareholders' Equity | |||||
Shares Outstanding, K | 20,982 | 18,580 | N/A | N/A | N/A |
Common Shares | 2 | 2 | 2 | N/A | N/A |
Retained earnings | -129,455 | -96,459 | -67,016 | -43,199 | -18,822 |
TOTAL | $51,365 | $78,744 | $105,997 | $36,029 | $-167 |
Total Liabilities And Equity | $77,283 | $93,755 | $122,048 | $39,772 | $1,846 |